These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19151793)

  • 1. Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones.
    Feuchtinger T; Pfeiffer M; Pfaffle A; Teltschik HM; Wernet D; Schumm M; Lotfi R; Handgretinger R; Lang P
    Bone Marrow Transplant; 2009 Jun; 43(11):875-81. PubMed ID: 19151793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia.
    Pfeiffer M; Schumm M; Feuchtinger T; Dietz K; Handgretinger R; Lang P
    Br J Haematol; 2007 Jul; 138(1):97-100. PubMed ID: 17555452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA and KIR polymorphisms affect NK-cell anti-tumor activity.
    Passweg JR; Huard B; Tiercy JM; Roosnek E
    Trends Immunol; 2007 Oct; 28(10):437-41. PubMed ID: 17825623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.
    Hasenkamp J; Borgerding A; Uhrberg M; Falk C; Chapuy B; Wulf G; Jung W; Trümper L; Glass B
    Scand J Immunol; 2008 Mar; 67(3):218-29. PubMed ID: 18226015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
    Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR2DS3 is associated with protection against acute myeloid leukemia.
    Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
    Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
    J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products.
    Sivori S; Falco M; Moretta L; Moretta A
    Trends Immunol; 2010 Aug; 31(8):289-94. PubMed ID: 20630802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer immunoglobulin-like receptors.
    Moretta L; Moretta A
    Curr Opin Immunol; 2004 Oct; 16(5):626-33. PubMed ID: 15342010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors.
    Re F; Staudacher C; Zamai L; Vecchio V; Bregni M
    Cancer; 2006 Aug; 107(3):640-8. PubMed ID: 16804934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
    Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
    J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
    Ruggeri L; Capanni M; Mancusi A; Urbani E; Perruccio K; Burchielli E; Tosti A; Topini F; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2004; 33(3):216-21. PubMed ID: 15528134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
    Ruggeri L; Capanni M; Mancusi A; Martelli MF; Velardi A
    Transpl Immunol; 2005 Aug; 14(3-4):203-6. PubMed ID: 15982564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taking license with natural killer cell maturation and repertoire development.
    Parham P
    Immunol Rev; 2006 Dec; 214():155-60. PubMed ID: 17100883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Aversa F; Martelli MF; Velardi A
    Cytotherapy; 2006; 8(6):554-8. PubMed ID: 17148031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands.
    Han M; Fallena M; Guo Y; Stastny P
    Hum Immunol; 2007 Jun; 68(6):507-13. PubMed ID: 17509450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.
    Marcenaro E; Carlomagno S; Pesce S; Della Chiesa M; Moretta A; Sivori S
    J Leukoc Biol; 2011 Oct; 90(4):661-7. PubMed ID: 21791599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.